Ending the HIV epidemic using community pharmacists

By Jan Jarvis

Precep Uk

Shelia Neal keeps a list of her prescriptions on her cell phone and puts her medications in a pill organizer.

“If I miss a dose, I might not die today, but I’m not going to feel good,” she said. “At the end of the day, I just have to take my medicine.”

The mother and grandmother is dedicated to staying healthy and having a good quality of life. She is determined to live well with HIV.

Both Neal and her pharmacist know failing to take HIV medicines correctly results in immune system failure and eventually death. To help more persons with HIV live like Neal, a clinical trial is now underway through the UNT System School of Pharmacy. It is designed to integrate pharmacists with primary care providers to deliver patient-centered care.

“The clinical trial is the only one in the world like this,” said Patrick Clay, PharmD, Professor of Pharmacotherapy. “Its simplicity is the key.”

Those with HIV are asked to meet with a community pharmacist every 90 days. The two have a private conversation about their medicines and their health and how to marry those two for the best outcome.

Evidence from a previous project suggests it is a successful approach.

From 2013 to 2017, Dr. Clay led a nationwide, multi-million dollar demonstration funded by the Centers for Disease Control and Prevention and Walgreens that formally linked pharmacists with persons with HIV treatment plans. Patients had regular one-on-one conversations with pharmacists. Two years later, success was realized. More patients stayed in care, took their medicine and kept HIV in check.Vertical2

“The project showed this simplistic approach could make a difference,” Dr. Clay said. “What was really meaningful was the group that benefited the most was African-Americans.”

While the prior project suggested this approach worked, stronger evidence was needed. Dr. Clay and his team are now conducting a formal clinical trial in the Fort Worth region to develop evidence for not only HIV but also diabetes and high blood pressure.

“The trial of HIV, diabetes and high blood pressure independently and collectively occur disproportionately in African Americans,” Dr. Clay said. “We are tackling them all at once.”

The current trial asks patients to meet privately with specially trained pharmacists every 90 days for two years. These pharmacists work closely with the patients’ physicians and other healthcare team members.

“The pharmacist can be a proactive member of the team, not just the person filling prescriptions,” Dr. Clay said. “And while doing so, persons with HIV will have better outcomes.”

Neal is a stronger believer in this approach. Those with HIV can always benefit from having more support.

“It takes a village,” she said.


Research reported in this publication was supported by the National Institute On Minority Health And Health Disparities of the National Institutes of Health under Award Number U54MD006882. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Recent News

Stephanie Ibekwe
  • Our People
|Dec 5, 2022

A voice for women in medicine

When Dr. Stephanie Ibekwe’s mother, Sarah, came home from her nursing job, she would tell her daughter stories about her patients and the conversations she had with them. “Nursing is pretty stressful, but my mom had an amazing way of handling things,” she said. “My mom really loved to bui...
Noah Peeri Headshot
  • Our People
|Dec 5, 2022

SPH alum Dr. Noah Peeri achieves JAMA Oncology publication just months after graduation

Noah Peeri, Ph.D., MPH, a recent graduate of The University of North Texas Health Science Center’s School of Public Health, has achieved a major milestone by publishing an article in the Journal of the American Medical Association Oncology just months after completing his graduate degree.   H...
Techstars Demo Day.
  • On Campus
|Dec 1, 2022

Techstars Demo Day brings innovation to the historic stockyards

For the last 13 weeks, the founders of 10 of the world’s most innovative startups have been in Fort Worth perfecting their new physical health technology. They are part of the world’s first physical health accelerator, and now they are ready to show the fruits of their labor. Techstars Demo D...
Dr. Sid O'bryant Award
  • Our People
|Dec 1, 2022

HSC named the winner of the D Magazines 2022 Achievement in Medical Research Award

The extensive research done by Dr. Sid O’Bryant and his team at the Institute of Translational Research has earned the University of North Texas Health Science Center at Fort Worth the 2022 Medical Research Award by D Magazine. Dr. O’Bryant, the executive director of the ITR and a professor at t...